The Effect of Topical Betamethasone Eye Drops on Postoperative Haze among Patients Undergoing Corneal Collagen Cross-Linking: a Randomized, Double Blind Placebo Controlled Study
Journal of Ophthalmic and Optometric Sciences,
Vol. 2 No. 2 (2018),
3 Farvardin 2018
,
Page 17-24
https://doi.org/10.22037/joos.v2i2.29323
Abstract
Objective: To evaluate the effect of topical betamethasone eye drops on postoperative haze among patients undergoing corneal collagen cross-linking (CXL).
Patients and Methods: Patients with mild to moderate keratoconus, aged 18 to 30 years, who were a candidate for CXL treatment and had the evidence of disease progression based on topographic findings entered the present study. One eye of each patient randomly received betamethasone and topical antibiotics after CXL and the other eye received topical antibiotics and placebo in place of betamethasone. The eyes were compared regarding BCVA, UCVA, refraction, keratometric and pachymetric findings using Pentacam, as well as changes of corneal haze using confocal microscopy, before CXL as well as one month and six months after CXL.
Results: There was no difference in BCVA, UCVA, refraction, keratometric and pachymetric findings between the two groups before and six months after surgery. Based on confocal findings, the difference in light reflectance intensity between the case and control groups was statistically significant in anterior (P = 0.021) and posterior (P = 0.017) corneal stroma one month postoperatively, indicating higher haze in the placebo group. This difference was also statistically significant in anterior (P = 0.001) mid (P = 0.002) and posterior (P = 0.002) stroma six months postoperatively.
Conclusion: Betamethasone had no effect on visual acuity, refraction, keratometric and pachymetric findings six months after CXL. It reduced corneal haze in both the first and the sixth months postoperatively.
Keywords: Keratoconus; Cornea; Cross-Linking; Haze; Betamethasone
How to Cite
References
Vazirani J, Basu S. Keratoconus: current perspectives. Clin Ophthalmol. 2013;7:2019-30.
Gomes JA, Tan D, Rapuano CJ, Belin MW, Ambrósio Jr R, Guell JL, et al. Global consensus on keratoconus and ectatic diseases. Cornea. 2015;34(4):359-69.
Kok YO, Tan GF, Loon SC. keratoconus in Asia. Cornea. 2012;31(5):581-93.
Radner W, Zehetmayer M, Skorpik C, Mallinger R. Altered organization of collagen in the apex of keratoconus corneas. Ophthalmic research. 1998;30(5):327-32.
Daxer A, Fratz P. Collagen fibril orientation in the human corneal stroma and its implication in keratoconus. Invest Ophthalmol Vis Sci. 1997;38(1):121-9.
Olivares Jiménez JL, Guerrero Jurado JC, Bermudez Rodriguez FJ, Serrano Laborda D. Keratoconus: age of onset and natural history. Optom Vis Sci. 1997;74(3):147-51.
Razmjoo H, Rahimi B, Kharraji M, Koosha N, Peyman A. Corneal haze and visual outcome after collagen crosslinking for keratoconus: A comparison between total epithelium off and partial epithelial removal methods. Adv Biomed Res. 2014;3:221.
Subasinghe SK, Ogbuehi KC, Dias GJ. Current perspectives on corneal collagen crosslinking (CXL). Graefes Arch Clin Exp Ophthalmol. 2018;256(8):1363-84.
Samaras KE, Lake DB. Corneal collagen cross linking (CXL): a review. Int Ophthalmol Clin. 2010;50(3):89-100.
Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol. 2003;135(5):620-7.
Abdolahian M, Zolghadr GH. Corneal Collagen Crosslinking for Treatment of Keratoconus. Journal of Ophthalmic and Optometric Sciences. 2017;1(4):8-14.
Wollensak G. Crosslinking treatment of progressive keratoconus: new hope. Curr Opin Ophthalmol. 2006;17(4):356-60.
Nassiri N, Azemati A. The Use of Corneal Cross-linking in Treatment of Progressive Keratoconus: a Review. Journal of Ophthalmic and Optometric Sciences. 2017;1(4):15-21.
Dhawan S, Rao K, Natrajan S. Complications of corneal collagen cross-linking. J Ophthalmol. 2011;2011:869015.
Pleyer U, Ursell PG, Rama P. Intraocular pressure effects of common topical steroids for post-cataract inflammation: are they all the same?. Ophthalmol Ther. 2013;2(2):55-72.
Nien CJ, Flynn KJ, Chang M, Brown D, Jester JV. Reducing peak corneal haze after photorefractive keratectomy in rabbits: prednisolone acetate 1.00% versus cyclosporine A 0.05%. J Cataract Refract Surg. 2011;37(5):937-44.
Vetrugno M, Maino A, Quaranta GM, Cardia L. The effect of early steroid treatment after PRK on clinical and refractive outcomes. Acta Ophthalmol Scand. 2001;79(1):23-7.
Wisse RP, Godefrooij DA, Soeters N, Imhof SM, Van der Lelij A. A multivariate analysis and statistical model for predicting visual acuity and keratometry one year after cross-linking for keratoconus. Am J Ophthalmol. 2014;157(3):519-25.
Lamy R, Netto CF, Reis RG, Procopio B, Porco TC, Stewart JM, et al. Effects of corneal cross-linking on contrast sensitivity, visual acuity, and corneal topography in patients with keratoconus. Cornea. 2013;32(5):591-6.
Greenstein SA, Fry KL, Bhatt J, Hersh PS. Natural history of corneal haze after collagen crosslinking for keratoconus and corneal ectasia: Scheimpflug and biomicroscopic analysis. J Cataract Refract Surg. 2010;36(12):2105-14.
- Abstract Viewed: 348 times
- PDF Downloaded: 197 times
